Featured in this edition of ISpeak Reading Roundup are the top blog posts from May 2019. Discover trending industry topics, developments for the future of pharma, and more for what the pharmaceutical industry was reading last month.
The pharma industry is ever-changing and developing new ways to move forward with science and technology. Pharma 4.0™ incorporates advanced technology to promote innovation and to provide more reliable and secure data. Learn how new technology and operations will propel the industry forward.
Consistency in reliable manufacturing and production systems is an increasingly necessary focus for pharmaceutical professionals in today’s industry. See how the pharma industry can meet new regulatory expectations and redefine good manufacturing practices in the age of complex technologies and treatments.
Biopharmaceutical production is readily adapting to new industry norms and creating opportunities for industry members to venture out of their comfort zone and embrace the future of biopharmaceuticals. Find out how biopharmaceutical production will change and what is expected from industry manufacturers.
This three-part water technology series reviews a redesigned system for increased product performance and cost reduction. Quality control and end-user perspectives of distillation procedures are addressed in this article.
Hear how risk management and FDA guidance can help ease the transition from past manufacturing procedures to complicated and multi-step manufacturing processes. The transition to and incorporation of new pharma tradition will prompt professionals to search for creative ways to overcome obstacles.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...